European Journal of Pharmacology

SGLT2 inhibition attenuates cytoskeletal and proteostatic dysfunction through the AGE-RAGE-IGFBP2-FBN1 signaling axis in diabetic lenses

Experiments in animalsInterventions

The paper

Kaohsiung Veterans General Hospital; National Sun Yat-sen University

European Journal of Pharmacology, 14 Aug 2026

doi.org/10.1016/j.ejphar.2026.179249PubMed 42601001